Francisco Javier Novo
Francisco Javier Novo
Department of Biochemistry and Genetics. University of Navarra. Spain
Verified email at
Cited by
Cited by
Recurrent involvement of the REL and BCL11Aloci in classical Hodgkin lymphoma
JI Martı́n-Subero, S Gesk, L Harder, T Sonoki, PW Tucker, ...
Blood 99 (4), 1474-1477, 2002
Cancer epigenetics and methylation.
M Esteller, MF Fraga, MF Paz, E Campo, D Colomer, FJ Novo, ...
Science (New York, NY) 297 (5588), 1807, 2002
SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia
I Cristóbal, FJ Blanco, L Garcia-Orti, N Marcotegui, C Vicente, J Rifon, ...
Blood 115 (3), 615-625, 2010
Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses
JI Martín-Subero, I Chudoba, L Harder, S Gesk, W Grote, FJ Novo, ...
The American journal of pathology 161 (2), 413-420, 2002
Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci
JI Martín‐Subero, L Harder, S Gesk, B Schlegelberger, W Grote, ...
International journal of cancer 98 (3), 470-474, 2002
Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients
X Agirre, JL Vizmanos, MJ Calasanz, M García-Delgado, MJ Larráyoz, ...
Oncogene 22 (7), 1070-1072, 2003
TICdb: a collection of gene-mapped translocation breakpoints in cancer
FJ Novo, IO de Mendíbil, JL Vizmanos
BMC genomics 8 (1), 1-5, 2007
NIN, a Gene Encoding a CEP110-Like Centrosomal Protein, Is Fused to PDGFRB in a Patient with at (5; 14)(q33; q24) and an Imatinib-Responsive Myeloproliferative Disorder 1
JL Vizmanos, FJ Novo, JP Román, EJ Baxter, I Lahortiga, MJ Larráyoz, ...
Cancer research 64 (8), 2673-2676, 2004
Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions
M Shugay, IO de Mendibil, JL Vizmanos, FJ Novo
Bioinformatics, 2013
TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia
X Agirre, FJ Novo, MJ Calasanz, MJ Larráyoz, I Lahortiga, M Valgañón, ...
Molecular carcinogenesis 38 (4), 201-208, 2003
Leptin Gene Transfer into Muscle Increases Lipolysis and Oxygen Consumption in White Fat Tissue in< i> ob</i>/< i> ob</i> Mice
A Marti, FJ Novo, E Martinez-Anso, M Zaratiegui, M Aguado, JA Martinez
Biochemical and biophysical research communications 246 (3), 859-862, 1998
Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties
G Garcı́a del Barrio, FJ Novo, JM Irache
Journal of controlled release 86 (1), 123-130, 2003
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2‐positive germinal center B‐cell lymphomas
JI Martín‐Subero, MD Odero, R Hernandez, JC Cigudosa, X Agirre, ...
Genes, Chromosomes and Cancer 43 (4), 414-423, 2005
Gene transfer and expression of human alpha-galactosidase from mouse muscle in vitro and in vivo.
FJ Novo, DC Gorecki, G Goldspink, KD MacDermot
Gene therapy 4 (5), 488, 1997
A novel gene, MDS2, is fused to ETV6/TEL in at (1; 12)(p36. 1; p13) in a patient with myelodysplastic syndrome
MD Odero, JL Vizmanos, JP Román, I Lahortiga, C Panizo, MJ Calasanz, ...
Genes, Chromosomes and Cancer 35 (1), 11-19, 2002
t (10; 16)(q22; p13) and MORF‐CREBBP fusion is a recurrent event in acute myeloid leukemia
JL Vizmanos, MJ Larráyoz, I Lahortiga, F Floristán, C Alvarez, MD Odero, ...
Genes, Chromosomes and Cancer 36 (4), 402-405, 2003
Editing of human α-galactosidase RNA resulting in a pyrimidine top purine conversion
FJ Novo, A Kruszewski, KD MacDermot, G Goldspink, DC Gorecki
Nucleic acids research 23 (14), 2636-2640, 1995
UCP2 muscle gene transfer modifies mitochondrial membrane potential
A Marti, E Larrarte, FJ Novo, M Garcia, JA Martinez
International journal of obesity 25 (1), 68-74, 2001
In vivo sustained release of adenoviral vectors from poly (D, L-lactic-co-glycolic) acid microparticles prepared by TROMS
G Garcı́a del Barrio, J Hendry, MJ Renedo, JM Irache, FJ Novo
Journal of controlled release 94 (1), 229-235, 2004
Optimisation of growth hormone production by muscle cells using plasmid DNA
GS MacColl, FJ Novo, NJ Marshall, M Waters, G Goldspink, PM Bouloux
Journal of endocrinology 165 (2), 329-336, 2000
The system can't perform the operation now. Try again later.
Articles 1–20